Detalhe da pesquisa
1.
Cutaneous melanoma.
Lancet
; 402(10400): 485-502, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499671
2.
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
Ann Surg Oncol
; 31(3): 1857-1864, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966706
3.
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Future Oncol
; 20(15): 959-968, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390818
4.
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach.
J Transl Med
; 21(1): 257, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055772
5.
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab.
J Transl Med
; 21(1): 753, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880788
6.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
J Transl Med
; 21(1): 508, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507765
7.
Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia.
Genet Med
; 25(12): 100970, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658729
8.
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
Ann Surg Oncol
; 29(5): 2871-2881, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142966
9.
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Ann Surg Oncol
; 29(6): 3694-3708, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089452
10.
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study.
Br J Dermatol
; 187(3): 401-410, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293617
11.
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Nature
; 532(7598): 250-4, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042933
12.
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
Australas J Dermatol
; 63(2): e133-e137, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188271
13.
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
Lancet Oncol
; 22(6): 836-847, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989557
14.
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
Br J Cancer
; 124(3): 574-580, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087895
15.
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
Ann Surg Oncol
; 28(8): 4561-4569, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393039
16.
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
Ann Surg Oncol
; 28(11): 6109-6123, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347220
17.
Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location.
Strahlenther Onkol
; 197(12): 1104-1112, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114045
18.
Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews.
BMC Cancer
; 21(1): 1014, 2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507552
19.
Recent advancements in melanoma management.
Intern Med J
; 51(3): 327-333, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738950
20.
Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy.
Cancer
; 126(1): 86-97, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584722